Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
1.81 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.352 | 0.526 | 0.265 | 0 | 0.166 | 0.094 | 0.071 | 0 | 0.079 | 0.002 | 0 |
| Brutowinst
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.352 | -0.526 | -0.265 | 0 | -0.166 | -0.094 | -0.071 | 0 | -0.079 | -0.002 | 0 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 6.858 | 5.584 | 5.784 | 8.476 | 8.717 | 8.991 | 5.235 | 6.297 | 2.306 | 4.514 | 5.83 | 2.663 | 1.423 | 0.374 | 0.391 | 0.295 | 0.001 | 0.036 | 0.271 | 0 | 0 | 0 | 0.032 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 1.604 | 2.545 | 2.138 | 1.512 | 1.992 | 3.079 | 1.501 | 1.477 | 1.257 | 1.005 | 1.62 | 1.302 | 1.053 | 1.416 | 1.481 | 0.527 | 0.511 | 0.741 | 0.347 | 0 | 0 | 0 | 0.139 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 1.604 | 2.545 | 2.138 | 1.512 | 1.992 | 3.079 | 1.501 | 1.477 | 1.257 | 1.005 | 1.62 | 1.302 | 1.053 | 1.416 | 1.481 | 0.527 | 0.511 | 0.741 | 0.347 | 0 | 0 | 0 | 0.139 | 0 | 0 | 0.013 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0.005 | -0 | -0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 8.463 | 8.13 | 7.922 | 9.988 | 10.709 | 12.071 | 6.736 | 7.774 | 3.563 | 5.519 | 7.45 | 3.965 | 2.477 | 1.79 | 1.872 | 0.527 | 0.512 | 0.777 | 0.618 | 0 | 0 | 0 | 0.171 | 0 | 0 | 0.013 |
| Bedrijfsresultaat
| -8.463 | -8.13 | -7.922 | -9.988 | -10.709 | -12.071 | -6.736 | -7.774 | -3.563 | -5.519 | -7.45 | -3.965 | -2.477 | -1.79 | -1.872 | -0.527 | -0.512 | -0.777 | -0.618 | -0.166 | -0.094 | -0.071 | -0.171 | -0.079 | -0.002 | -0.013 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 0.097 | 0.277 | 0.496 | 0.26 | 0.144 | -0.456 | 0.136 | -0.336 | 0.05 | 0.186 | 0.089 | 0.278 | 0.2 | 0.189 | 0.923 | 0.523 | -0.146 | -0.074 | -0.13 | 0.303 | 0.368 | 0.41 | -0.144 | 0.342 | 0.02 | 0 |
| Inkomen voor belasting
| -8.366 | -7.853 | -7.426 | -9.729 | -10.479 | -12.436 | -6.6 | -8.11 | -3.513 | -5.334 | -7.361 | -3.685 | -2.277 | -1.605 | -0.949 | -1.524 | -0.659 | -0.851 | -0.748 | 0.137 | 0.274 | 0.338 | -0.314 | 0.263 | 0.018 | -0.013 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0.007 | 0.007 | -0.005 | 0.012 | 0.006 | 0.003 | 0.008 | 0.002 | 0.007 | 0.004 | -0.274 | 0.002 | 0.004 | 0.001 | -0.001 | 0.001 | 0.025 | 0.001 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 |
| Nettowinst
| -8.366 | -7.86 | -7.434 | -9.724 | -10.491 | -12.443 | -6.603 | -8.118 | -3.515 | -5.341 | -7.365 | -3.685 | -2.279 | -1.608 | -0.949 | -1.524 | -0.659 | -0.851 | -0.749 | 0.137 | 0.274 | 0.338 | -0.315 | 0.263 | 0.018 | -0.013 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.25 | -0.26 | -0.25 | 0 | -0.44 | -0.55 | -0.3 | -0.42 | -0.18 | -0.29 | -0.4 | -0.29 | -0.12 | -0.12 | -0.1 | -0.17 | -0.24 | -0.31 | -0.27 | 0.052 | 0.11 | 0.13 | -0.017 | 0.1 | 0.012 | -0.01 |
| Verwaterde WPA
| -0.25 | -0.26 | -0.25 | 0 | -0.44 | -0.55 | -0.3 | -0.42 | -0.18 | -0.29 | -0.4 | -0.29 | -0.12 | -0.12 | -0.1 | -0.17 | -0.24 | -0.31 | -0.27 | 0.052 | 0.11 | 0.13 | -0.017 | 0.1 | 0.012 | -0.01 |
| EBITDA
| 0 | -7.847 | -7.423 | -9.387 | -10.612 | -11.967 | -6.603 | -7.312 | -3.563 | -5.698 | -7.539 | -3.965 | -2.477 | -1.79 | -1.872 | -0.446 | -0.512 | -0.752 | -0.618 | -0.166 | -0.094 | -0.071 | -0.171 | -0.079 | -0.002 | -0.013 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |